Viewing Study NCT00054561


Ignite Creation Date: 2025-12-24 @ 12:53 PM
Ignite Modification Date: 2026-01-28 @ 4:22 AM
Study NCT ID: NCT00054561
Status: COMPLETED
Last Update Posted: 2023-06-15
First Post: 2003-02-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Sponsor: Eastern Cooperative Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III squamous cell carcinoma of the lip and oral … View
None stage IV squamous cell carcinoma of the lip and oral … View
None stage III squamous cell carcinoma of the oropharynx View
None stage IV squamous cell carcinoma of the oropharynx View
None stage III squamous cell carcinoma of the larynx View
None stage IV squamous cell carcinoma of the larynx View
None stage III squamous cell carcinoma of the hypopharynx View
None stage IV squamous cell carcinoma of the hypopharynx View